|
MX2019010960A
|
|
Npra agonists, compositions, and uses thereof.
|
|
KR20170109526A
|
|
Method of production of graft co-polymer excipient with a superior peptide and protein binding property
|
|
CN105396139A
|
|
Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same
|
|
US2010069293A1
|
|
Polymeric carrier compositions for delivery of active agents, methods of making and using the same
|
|
WO2009114520A2
|
|
Compositions for treatment with metallopeptidases, methods of making and using the same
|
|
WO2009065077A1
|
|
Cationic-core carrier compositions for delivery of therapeutic agents, methods of making and using the same
|
|
US2009088387A1
|
|
Composition for long-acting peptide analogs
|
|
US2009176892A1
|
|
Soluble Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same
|
|
US2008015263A1
|
|
Compositions for delivery of therapeutics and other materials
|
|
CA2633070A1
|
|
Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same
|
|
US2006093660A1
|
|
Compositions for treatment with glucagon-like peptide, and methods of making and using the same
|
|
EP1478406A1
|
|
Compositions for delivery of therapeutics and other materials, and methods of making and using the same
|
